Differential expression and activity of matrix metalloproteinase-2 and -9 in the calreticulin deficient cells

Matrix Biology

Volumn 26, Issue 6, 2007, Pages 463-472

  Wu, Min ^a   Massaeli, Hamid ^b   Durston, Melanie ^a   Mesaeli, Nasrin ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Calreticulin; Matrix metalloproteinase 2; MEK; MMP 9; MT1 MMP; PI3 kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALRETICULIN; GELATINASE A; GELATINASE B; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE DELETION; HEART DEVELOPMENT; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 34447637646     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2007.02.005     Document Type: Article

References (36)

1. Bornstein P., Agah A., and Kyriakides T.R. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol. 36 (2004) 1115-1125
2. Cowell S., Knauper V., Stewart M.L., D'Ortho M.P., Stanton H., Hembry R.M., Lopez-Otin C., Reynolds J.J., and Murphy G. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem. J. 331 Pt 2 (1998) 453-458
3. Creemers E.E., Cleutjens J.P., Smits J.F., and Daemen M.J. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?. Circ. Res. 89 (2001) 201-210
4. Donnini S., Morbidelli L., Taraboletti G., and Ziche M. ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. Life Sci. 74 (2004) 2975-2985
5. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev., Cancer 2 (2002) 161-174
6. Ellgaard L., and Frickel E.M. Calnexin, calreticulin, and ERp57: teammates in glycoprotein folding. Cell Biochem. Biophys. 39 (2003) 223-247
7. Esparza J., Vilardell C., Calvo J., Juan M., Vives J., Urbano-Marquez A., Yague J., and Cid M.C. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94 (1999) 2754-2766
8. Guo L., Groenendyk J., Papp S., Dabrowska M., Knoblach B., Kay C., Parker J.M., Opas M., and Michalak M. Identification of an N-domain histidine essential for chaperone function in calreticulin. J. Biol. Chem. 278 (2003) 50645-50653
9. Hofmann U.B., Westphal J.R., Van Kraats A.A., Ruiter D.J., and Van Muijen G.N. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo. Int. J. Cancer 87 (2000) 12-19
10. Knipp B.S., Ailawadi G., Ford J.W., Peterson D.A., Eagleton M.J., Roelofs K.J., Hannawa K.K., Deogracias M.P., Ji B., Logsdon C., Graziano K.D., Simeone D.M., Thompson R.W., Henke P.K., Stanley J.C., and Upchurch Jr. G.R. Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear factor-kappaB and activator protein-1 activity. J. Surg. Res. 116 (2004) 70-80
11. Lafleur M.A., Tester A.M., and Thompson E.W. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism. FEBS Lett. 553 (2003) 457-463
12. Li H., Simon H., Bocan T.M., and Peterson J.T. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Cardiovasc. Res. 46 (2000) 298-306
13. Lijnen H.R. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury. Verh. K. Acad. Geneeskd. Belg. 63 (2001) 605-622
14. Lohi J., and Keski-Oja J. Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J. Biol. Chem. 270 (1995) 17602-17609
15. Marcet-Palacios M., Graham K., Cass C., Befus A.D., Mayers I., and Radomski M.W. Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. J. Pharmacol. Exp. Ther. 307 (2003) 429-436
16. McCawley L.J., and Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today 6 (2000) 149-156
17. 2+ influx. J. Biol. Chem. 271 (1996) 9332-9339
18. Mesaeli N., and Phillipson C. Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol. Biol. Cell 15 (2004) 1862-1870
19. Mesaeli N., Nakamura K., Zvaritch E., Dickie P., Dziak E., Krause K.H., Opas M., MacLennan D.H., and Michalak M. Calreticulin is essential for cardiac development. J. Cell Biol. 144 (1999) 857-868
20. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., and Opas M. Calreticulin: one protein, one gene, many functions. Biochem. J. 344 Pt 2 (1999) 281-292
21. Mukhopadhyay S., Munshi H.G., Kambhampati S., Sassano A., Platanias L.C., and Stack M.S. Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma. J. Biol. Chem. 279 (2004) 33139-33146
22. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
23. Ogawa K., Chen F., Kuang C., and Chen Y. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem. J. 381 (2004) 413-422
24. Okada Y., Eibl G., Duffy J.P., Reber H.A., and Hines O.J. Glial cell-derived neurotrophic factor upregulates the expression and activation of matrix metalloproteinase-9 in human pancreatic cancer. Surgery 134 (2003) 293-299
25. Pyo R., Lee J.K., Shipley J.M., Curci J.A., Mao D., Ziporin S.J., Ennis T.L., Shapiro S.D., Senior R.M., and Thompson R.W. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105 (2000) 1641-1649
26. Rauch F., Prud'homme J., Arabian A., Dedhar S., and St-Arnaud R. Heart, brain, and body wall defects in mice lacking calreticulin. Exp. Cell Res. 256 (2000) 105-111
27. Shin I., Kim S., Song H., Kim H.R., and Moon A. H-ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J. Biol. Chem. 280 (2005) 14675-14683
28. 2+. J. Invest. Dermatol. 112 (1999) 957-964
29. Spinale F.G., Coker M.L., Heung L.J., Bond B.R., Gunasinghe H.R., Etoh T., Goldberg A.T., Zellner J.L., and Crumbley A.J. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 102 (2000) 1944-1949
30. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., and Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270 (1995) 5331-5338
31. Ulku A.S., Schafer R., and Der C.J. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells. Mol. Cancer. Res. 1 (2003) 1077-1088
32. Waser M., Mesaeli N., Spencer C., and Michalak M. Regulation of calreticulin gene expression by calcium. J. Cell Biol. 138 (1997) 547-557
33. Yoon A., and Hurta R.A. Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells. Mol. Cell. Biochem. 223 (2001) 1-6
34. Zhang D., and Brodt P. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Oncogene 22 (2003) 974-982
35. Zhang D., Bar-Eli M., Meloche S., and Brodt P. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J. Biol. Chem. 279 (2004) 19683-19690
36. Zucker S., Hymowitz M., Conner C., DeClerck Y., and Cao J. TIMP-2 is released as an intact molecule following binding to MT1-MMP on the cell surface. Exp. Cell Res. 293 (2004) 164-174